Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga · 04/08 12:35
U.S. stock futures were higher this morning, with the Dow futures gaining more than 900 points on Tuesday.
Shares of The Greenbrier Companies, Inc. (NYSE:GBX) fell sharply in today's pre-market trading as the company posted downbeat results for its second quarter.
Greenbrier reported quarterly earnings of $1.56 per share which missed the analyst consensus estimate of $1.78 per share. The company reported quarterly sales of $762.100 million which missed the analyst consensus estimate of $898.530 million.
Greenbrier shares dipped 3.9% to $43.00 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- CVRx, Inc. (NASDAQ:CVRX) shares dipped 29.8% to $8.10 in today's pre-market trading after the company reported preliminary first quarter 2025 financial results.
- Collective Mining Ltd. (NYSE:CNL) declined 12.2% to $7.31 in pre-market trading.
- InnovAge Holding Corp. (NASDAQ:INNV) fell 11.2% to $2.70 in pre-market trading after gaining over 7% on Monday.
- PureTech Health plc (NASDAQ:PRTC) dipped 11% to $16.02 in pre-market trading.
- Emerald Holding, Inc. (NYSE:EEX) fell 7.5% to $3.2100 in pre-market trading.
- Celcuity Inc. (NASDAQ:CELC) dipped 7.1% to $8.51 in pre-market trading. Celcuity recently reported a year-over-year decrease in fourth-quarter EPS results.
- RPM International Inc. (NYSE:RPM) fell 5.9% to $100.40 in pre-market trading following weaker-than-expected quarterly results.
- Maze Therapeutics, Inc. (NASDAQ:MAZE) fell 4.5% to $8.52 in pre-market trading.
- Enliven Therapeutics, Inc. (NASDAQ:ELVN) declined 3.8% to $17.20 in pre-market trading.
Now Read This:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.